These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 35699384)
1. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Lath A; Santal AR; Kaur N; Kumari P; Singh NP Biotechnol Genet Eng Rev; 2023 Apr; 39(1):45-84. PubMed ID: 35699384 [TBL] [Abstract][Full Text] [Related]
2. Anticancer potential of bioactive peptides from animal sources (Review). Wang L; Dong C; Li X; Han W; Su X Oncol Rep; 2017 Aug; 38(2):637-651. PubMed ID: 28677775 [TBL] [Abstract][Full Text] [Related]
3. Anti-Cancer Peptides: Status and Future Prospects. Ghaly G; Tallima H; Dabbish E; Badr ElDin N; Abd El-Rahman MK; Ibrahim MAA; Shoeib T Molecules; 2023 Jan; 28(3):. PubMed ID: 36770815 [TBL] [Abstract][Full Text] [Related]
6. Identification of functional peptides from natural and synthetic products on their anticancer activities by tumor targeting. Ko JK; Auyeung KK Curr Med Chem; 2014; 21(21):2346-56. PubMed ID: 24524767 [TBL] [Abstract][Full Text] [Related]
7. Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications. Chinnadurai RK; Khan N; Meghwanshi GK; Ponne S; Althobiti M; Kumar R Biomed Pharmacother; 2023 Aug; 164():114996. PubMed ID: 37311281 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the use of therapeutic peptides for cancer treatment. Marqus S; Pirogova E; Piva TJ J Biomed Sci; 2017 Mar; 24(1):21. PubMed ID: 28320393 [TBL] [Abstract][Full Text] [Related]
9. Bioactive Peptides: Potential Impact on the Treatment of Gastrointestinal Cancers. Pourali G; Kazemi D; Pourali R; Rahmani N; Razzaghi E; Maftooh M; Fiuji H; Ghorbani E; Khazaei M; Ferns GA; Hassanian SM; Avan A Curr Pharm Des; 2023; 29(31):2450-2460. PubMed ID: 37877510 [TBL] [Abstract][Full Text] [Related]
10. Peptides for diagnosis and treatment of colorectal cancer. Shapira S; Fokra A; Arber N; Kraus S Curr Med Chem; 2014; 21(21):2410-6. PubMed ID: 24524764 [TBL] [Abstract][Full Text] [Related]
12. Peptide-based cancer therapy: opportunity and challenge. Wu D; Gao Y; Qi Y; Chen L; Ma Y; Li Y Cancer Lett; 2014 Aug; 351(1):13-22. PubMed ID: 24836189 [TBL] [Abstract][Full Text] [Related]
13. Pleiotropic Anticancer Properties of Scorpion Venom Peptides: Mikaelian AG; Traboulay E; Zhang XM; Yeritsyan E; Pedersen PL; Ko YH; Matalka KZ Drug Des Devel Ther; 2020; 14():881-893. PubMed ID: 32161447 [TBL] [Abstract][Full Text] [Related]
14. Membrane disrupting lytic peptides for cancer treatments. Leuschner C; Hansel W Curr Pharm Des; 2004; 10(19):2299-310. PubMed ID: 15279610 [TBL] [Abstract][Full Text] [Related]
15. Survey of In-silico Prediction of Anticancer Peptides. Ye N Curr Top Med Chem; 2021; 21(15):1310-1318. PubMed ID: 34126901 [TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy. Min KA; Maharjan P; Ham S; Shin MC Arch Pharm Res; 2018 Jun; 41(6):594-616. PubMed ID: 29804279 [TBL] [Abstract][Full Text] [Related]
17. Biomedical Applications of a Novel Class of High-Affinity Peptides. Saw PE; Xu X; Kim S; Jon S Acc Chem Res; 2021 Sep; 54(18):3576-3592. PubMed ID: 34406761 [TBL] [Abstract][Full Text] [Related]
18. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Xie M; Liu D; Yang Y Open Biol; 2020 Jul; 10(7):200004. PubMed ID: 32692959 [TBL] [Abstract][Full Text] [Related]
19. Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy. Sivashankari PR; Prabaharan M Curr Cancer Drug Targets; 2016; 16(6):522-35. PubMed ID: 26632433 [TBL] [Abstract][Full Text] [Related]